Comparison the clinical effect of berry extract and Desmopressin in primary mono symptomatic nocturnal enuresis

Study the clinical effect of berry extract and comparison with Desmopressin in 6-12 children with primary mono symptomatic nocturnal enuresis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160306026938N11

Enrollment

Registered

2022-09-15

Start date

2022-07-22

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mono-symptomatic nocturnal enuresis. Overflow Reflex Urge incontinence

Interventions

Intervention 1: Intervention group: Berry hydroalcoholic extract syrup (7.5 ml twice a day), is equal to 20 grams of fruit per day, for 2 consecutive weeks. Intervention 2: C??ontrol group: Desmopress

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Children between 6-12 years old Satisfied parents for participating in study. Not suffered from incurable and underlying disease Suffered from mono symptomatic nocturnal enuresis

Exclusion criteria

Exclusion criteria: Children out of range 6-12 years old Lack of permission of parents for participating in study Suffered from incurable and underlying disease Not suffered from mono symptomatic nocturnal enuresis

Design outcomes

Primary

Measure	Time frame
Frequency of wet nights in a weekchildren. Timepoint: Before intervention and 4 weeks after beginning the intervention and 2 weeks after cessation of intervention. Method of measurement: Parent’s report in questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Vazirian

Tehran University of Medical Sciences

Vazirian_m@tums.ac.ir+98 21 6412 1223

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026